The targeting construct contains a T167D (threonine to aspartic acid; ACC to GAC) substitution in exon 4, an EcoRI site in intron 3, and a self-excising loxP-flanked cre-neo cassette (ACN) in intron 4. (J:282714)
查看原文 参与反馈
The targeting construct contains a T167D (threonine to aspartic acid; ACC to GAC) substitution in exon 4, an EcoRI site in intron 3, and a self-excising loxP-flanked cre-neo cassette (ACN) in intron 4. (J:282714)